| ［1］ |
中国医师协会皮肤科医师分会皮肤美容亚专业委员会. 中国玫瑰痤疮诊疗专家共识（2016） ［J］. 中华皮肤科杂志, 2017,50（3）:156⁃161. doi: 10.3760/cma.issn.0412⁃4030.2017.03.002.
|
| ［2］ |
Asai Y, Tan J, Baibergenova A, et al. Canadian Clinical Practice Guidelines for rosacea［J］. J Cutan Med Surg, 2016,20（5）:432⁃445. doi: 10.1177/1203475416650427.
|
| ［3］ |
Anzengruber F, Czernielewski J, Conrad C, et al. Swiss S1 guideline for the treatment of rosacea［J］. J Eur Acad Dermatol Venereol, 2017,31（11）:1775⁃1791. doi: 10.1111/jdv.14349.
|
| ［4］ |
Schaller M, Almeida LM, Bewley A, et al. Rosacea treatment update: recommendations from the global ROSacea COnsensus （ROSCO） panel［J］. Br J Dermatol, 2017,176（2）:465⁃471. doi: 10.1111/bjd.15173.
|
| ［5］ |
Piwnica D, Rosignoli C, de Ménonville ST, et al. Vasoconstriction and anti⁃inflammatory properties of the selective α⁃adrenergic receptor agonist brimonidine［J］. J Dermatol Sci, 2014,75（1）:49⁃54. doi: 10.1016/j.jdermsci.2014.04.002.
|
| ［6］ |
Moore A, Kempers S, Murakawa G, et al. Long⁃term safety and efficacy of once⁃daily topical brimonidine tartrate gel 0.5 for the treatment of moderate to severe facial erythema of rosacea: results of a 1⁃year open⁃label study［J］. J Drugs Dermatol, 2014,13（1）:56⁃61.
|
| ［7］ |
Hsu CC, Lee JY. Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonse⁃lective β⁃adrenergic blocker［J］. J Am Acad Dermatol, 2012,67（3）:491⁃493. doi: 10.1016/j.jaad.2012.04.017.
|
| ［8］ |
Arumanayagam M, Chan S, Tong S, et al. Antioxidant properties of carvedilol and metoprolol in heart failure: a double⁃blind randomized controlled trial［J］. J Cardiovasc Pharmacol, 2001,37（1）:48⁃54.
|
| ［9］ |
van Zuuren EJ, Kramer SF, Carter BR, et al. Effective and evidence⁃based management strategies for rosacea: summary of a Cochrane systematic review［J］. Br J Dermatol, 2011,165（4）:760⁃781. doi: 10.1111/j.1365⁃2133.2011.10473.x.
|
| ［10］ |
Kim MB, Kim GW, Park HJ, et al. Pimecrolimus 1 cream for the treatment of rosacea［J］. J Dermatol, 2011,38（12）:1135⁃1139. doi: 10.1111/j.1346⁃8138.2011.01223.x.
|
| ［11］ |
Garg G, Thami GP. Clinical efficacy of tacrolimus in rosacea［J］. J Eur Acad Dermatol Venereol, 2009,23（2）:239⁃240. doi: 10.1111/j.1468⁃3083.2008.02822.x.
|
| ［12］ |
Teraki Y, Hitomi K, Sato Y, et al. Tacrolimus⁃induced rosacea⁃like dermatitis: a clinical analysis of 16 cases associated with tacrolimus ointment application［J］. Dermatology, 2012,224（4）:309⁃314. doi: 10.1159/000338693.
|
| ［13］ |
El⁃Heis S, Buckley DA. Rosacea⁃like eruption due to topical pimecrolimus［J/OL］. Dermatol Online J, 2015,21（5）. pii: 13030/qt7kd1048m.
|
| ［14］ |
Patel NU, Shukla S, Zaki J, et al. Oxymetazoline hydrochloride cream for facial erythema associated with rosacea［J］. Expert Rev Clin Pharmacol, 2017,10（10）:1049⁃1054. doi: 10.1080/17512433. 2017.1370370.
|
| ［15］ |
Narayanan S, Hünerbein A, Getie M, et al. Scavenging properties of metronidazole on free oxygen radicals in a skin lipid model system［J］. J Pharm Pharmacol, 2007,59（8）:1125⁃1130. doi: 10.1211/jpp.59.8.0010.
|
| ［16］ |
Schulte BC, Wu W, Rosen T. Azelaic acid: evidence⁃based update on mechanism of action and clinical application［J］. J Drugs Dermatol, 2015,14（9）:964⁃968.
|
| ［17］ |
Schaller M, Gonser L, Belge K, et al. Dual anti⁃inflammatory and anti⁃parasitic action of topical ivermectin 1 in papulopustular rosacea［J］. J Eur Acad Dermatol Venereol, 2017,31（11）:1907⁃1911. doi: 10.1111/jdv.14437.
|
| ［18］ |
Leyden JJ. Randomized, phase 2, dose⁃ranging study in the treatment of rosacea with encapsulated benzoyl peroxide gel［J］. J Drugs Dermatol, 2014,13（6）:685⁃688.
|
| ［19］ |
Del RJQ, Schlessinger J, Werschler P. Comparison of anti⁃inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea［J］. J Drugs Dermatol, 2008,7（6）:573⁃576.
|
| ［20］ |
Schaller M, Schöfer H, Homey B, et al. State of the art: systemic rosacea management［J］. J Dtsch Dermatol Ges, 2016,14 Suppl 6:29⁃37. doi: 10.1111/ddg.13141.
|
| ［21］ |
郝飞, 宋志强. 提高对玫瑰痤疮的认识水平［J］. 中华皮肤科杂志, 2017,50（3）:153⁃155. doi: 10.3760/cma.j.issn.0412⁃4030.2017. 03.001.
|
| ［22］ |
Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review［J］. Clin Ther, 2005,27（9）:1329⁃1342. doi: 10. 1016/j.clinthera.2005.09.005.
|
| ［23］ |
Noguera⁃Morel L, Gerlero P, Torrelo A, et al. Ivermectin therapy for papulopustular rosacea and periorificial dermatitis in children: A series of 15 cases［J］. J Am Acad Dermatol, 2017,76（3）:567⁃570. doi: 10.1016/j.jaad.2016.10.034.
|
